Inventor profile of:

Catalin Nistor

City:

Lund

Country:

Sweden

Published Applications:

29

Last publication date:

2026-01-01

Top Assignees for applications by Catalin Nistor

The entities that hold a legal rights for patent applications filed by inventor Nistor Catalin:

Recent patent applications by Nistor Catalin

Catalin Nistor from Lund, SE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-01-01
US20260000730A1
Human necessities

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

#2 | 2025-11-13
US20250345385A1
Human necessities

MIXTURES AND FORMULATIONS COMPRISING AN ALKYL AMMONIUM EDTA SALT

#3 | 2025-10-23
US20250325626A1
Human necessities

LIPID-CONTROLLED RELEASE COMPOSITIONS

#4 | 2025-10-16
US20250319097A1
Human necessities

PROSTACYCLIN ANALOGUE FORMULATIONS

#5 | 2025-04-17
US20250121035A1
Human necessities

CONTROLLED RELEASE PEPTIDE FORMULATIONS

#6 | 2025-01-02
US20250000982A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#7 | 2023-11-23
US20230372436A1
Human necessities

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

#8 | 2023-09-14
US20230285502A1
Human necessities

MIXTURES AND FORMULATIONS

#9 | 2022-12-08
US20220387445A1
Human necessities

PROSTACYCLIN ANALOGUE FORMULATIONS

#10 | 2022-08-18
US20220257694A1
Human necessities

Mixtures and formulations

#11 | 2022-06-30
US20220202898A1
Human necessities

Lipid-controlled release compositions

#12 | 2022-06-02
US20220168381A1
Human necessities

Formulations containing a somatostatin receptor agonist

#13 | 2021-10-07
US20210308226A1
Human necessities

CONTROLLED RELEASE PEPTIDE FORMULATIONS

#14 | 2021-09-02
US20210268112A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#15 | 2021-01-14
US20210008151A1
Human necessities

Formulations containing a somatostatin receptor agonist

#16 | 2020-05-07
US20200138954A1
Human necessities

Mixtures and formulations comprising an alkyl ammonium EDTA salt

#17 | 2019-11-21
US20190350841A1
Human necessities

LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT

#18 | 2019-08-29
US20190262419A1
Human necessities

Formulations containing a somatostatin receptor agonist

#19 | 2019-08-22
US20190255068A1
Human necessities

Prostacyclin analogue formulations

#20 | 2019-02-21
US20190054177A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#21 | 2018-07-26
US20180207089A1
Human necessities

ACID CONTAINING LIPID FORMULATIONS

#22 | 2017-10-05
US20170281537A1
Human necessities

LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT

#23 | 2015-12-24
US20150366973A1
Human necessities

PEPTIDE SLOW-RELEASE FORMULATIONS

#24 | 2015-04-16
US20150105332A1
Human necessities

Somatostatin receptor agonist formulations

#25 | 2014-06-12
US20140162944A1
Human necessities

Controlled release peptide formulations

#26 | 2012-02-02
US20120028890A1
Human necessities

Acid containing lipid formulations

#27 | 2011-09-22
US20110230569A1
Human necessities

Lipid formulations comprising a thiolated antioxidant

#28 | 2010-08-19
US20100210519A1
Human necessities

Peptide slow-release formulations

#29 | 2008-05-29
US20080124394A1
Human necessities

Controlled-release formulations

InventorID:

796928 ⎘